Dimiter Stanchev DimitrovBsc, PhD
Dr. Dimitrov graduated and completed his PhD at the University of Sofia, Sofia, Bulgaria, and thereafter he worked in the Bulgarian Academy of Sciences where he defended his ScD and was Professor of Biophysics until he joined the National Cancer Institute (NCI) of the National Institutes of Health (NIH), USA, in 1990. There he was tenured as Senior Investigator and appointed at the Senior Biomedical Research Service. He left for the University of Pittsburgh in 2017 to start a Center for Antibody Therapeutics. He is expert in display/screening/libraries methodologies, antibody engineering, and protein biochemistry as well as in mathematical modeling, immunology, virology, physical chemistry and biophysics.
His major long-term goal is the development of clinically useful therapeutics and vaccines based on human monoclonal antibodies in different formats including engineered antibody domains, chimeric antigen receptors, bispecific antibodies, and antibody-drug conjugates. He has authored or coauthored more than 370 articles cited more than 20,000 times, several books and is inventor or coinventor of more than 100 inventions, patent applications or patents.